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The present study investigates the effect of cinnamon (Cinnamomum zeylanicumon) powder 
supplementation on glucose levels, lipid profiles, and oxidative stress parameters in alloxan-induced 
diabetic rats. Diabetes was induced in adult male Wistar rats via a single subcutaneous alloxan injection 
(15 mg/kg). Cinnamon powder was mixed with the standard feed of the rats in an amount of 5% for 28 
consecutive days. Serum concentrations of total cholesterol (TC) and triglycerides (TG) were assayed at 
the end of the experimental period in all investigated groups. Anti-oxidative enzymes such as glutathione 
peroxidase (GPx), catalase (CAT) and superoxide dismutase (SOD) were sought in the serum and pancreas. 
Alloxan caused the fasting blood sugar level to increase. The administration of cinnamon blocked the 
increase of blood glucose. There was also a significant difference in the TG and TC levels between control 
and treated diabetic rats. In diabetic rats, cinnamon treatment restored the activities of SOD, CAT and 
GPx. These findings suggested that cinnamon has an anti-hyperglycemic effect, improves lipid profiles, 
and protect against damage induced by oxidative stress in the diabetic state. 
Keywords: Cinnamon/extract/antidiabetic activity. Cinnamon/extract/antihyperlipidemic activity. 
Cinnamon/extract/antioxidant activity. 
INTRODUCTION
Diabetes mellitus is a major disease around the world 
characterized by a serious, complex and chronic condition. 
This metabolic disorder affects approximately 4% of the 
population worldwide and is expected to increase by 5.4% 
in 2025 (Kim, Hyun, Choung, 2006). Diabetes mellitus, 
distinguished by hyperglycemia, is associated with 
disturbances in carbohydrate, protein and fat metabolism. 
Patients with diabetes mellitus have increased oxidative 
stress and impaired antioxidant defense systems, which 
appear to contribute to the initiation and progression of 
diabetes-associated complications (Maritim, Sanders, 
Watkins, 2003). The elevated glucose concentration 
directly injures cells and induces lipid peroxidation (Davi, 
Falco, Patrono, 2005). Alterations in antioxidant defense 
system enzymes such as catalase (CAT), glutathione 
peroxidase (GPx), superoxide dismutase (SOD) have 
been demonstrated in diabetic patients (Maritim, Sanders, 
Watkins, 2003). Moroever, oxidative stress marker 
increases in pancreatic islets have been reported in 
experimental diabetic rats (Ihara et al., 1999). 
The induction of experimental diabetes in the rat 
using chemicals which selectively destroy pancreatic β 
cells is very convenient and simple to use. The most usual 
substances to induce diabetes in the rat are alloxan and 
streptozotocin. The understanding of changes in β-cells of 
the pancreas as well as in the whole organism after alloxan 
or streptozotocin treatment is essential for using these 
compounds as diabetogenic agents (Szkudelski, 2001). 
The major mode of controlling diabetes can be 
achieved by diet, exercise and insulin replacement 
therapy (Pankaj, 2007). The use of hypoglycemic drugs, 
like insulin, biguanides, sulfoylureas and α-glucosidase 
inhibitors are accompanied by unpleasant side effects such 
as severe hypoglycemia, lactic acidosis, peripheral edema 
and abdominal discomfort (Ghorbani, 2013). Synthetic 
hypoglycemic agents produce serious side effects, whereas 
bioactive compounds derived from natural resources are 
regarded as safe and cost effective (Rao, Jamil, 2011). As 
reported by Aidi Wannes and Marzouk (2016), several 
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plants have been traditionally recommended for the 
treatment of diabetes and the role of these plants in the 
management of diabetes has been determined by many 
studies. More than 400 plant species having hypoglycemic 
activity have been available in literature, however, 
searching for new antidiabetic, antihyperlipidemic and 
antioxidant drugs from natural plants is still attractive 
(Balamurugan, Nishanthini, Mohan, 2014).
Cinnamon (Cinnamomum zeylanicumon) is an 
evergreen tree belonging to the Lauraceae family, 
traditionally harvested in Asian countries. It is one of the 
oldest herbal medicines mentioned in Chinese scripts as 
early as 4,000 years ago (Torizuka, 1998). The dried barks 
of Cinnamon are used to flavor or season various foods, 
and as a therapeutic agent for various diseases. Cinnamon 
is rich in essential oils and tannins. It possesses significant 
antidiabetic, antiallergic, antiulcerogenic, antipyretic and 
antioxidant properties (Kurokawa et al., 1998; Dhuley, 
1999; Dahankumar, Kulkarni, Rege, 2000; Khan, Safdar, 
2003). 
Due to the anti-hyperglycemic, anti-lipidemic 
and antioxidant properties of cinnamon, the aim of the 
present study was to evaluate the effect of cinnamon 
powder supplementation on abnormal glucose, lipid and 
antioxidant enzyme profiles in alloxan- induced diabetic 
rats.
MATERIAL AND METHODS
Animals
Adult male Wistar rats (190 g to 230 g) were used 
for the study. They were procured from Pasteur Institute of 
Tunis and maintained in the Faculty of Medicine of Tunis. 
The animals were individually housed under controlled 
temperature and hygienic conditions in polypropylene 
cages. Rats were maintained in an air-conditioned room 
(21±1 °C) with 12 h light: 12 h dark cycles. The relative 
humidity was maintained at 80%. They all received a 
standard pellet diet and water ad libitum.
The rats were allowed to acclimatize to the laboratory 
environment for 7 days before the start of the experiment. 
The standard diet contained 39.3% corn starch, 20% 
casein, 15.5% corn oil, 15.4% sucrose, 5% cellulose, 3.5% 
salt mixture, 1% vitamin mixture and 0.3% methionine. 
Throughout the study, rats were assessed weekly for body 
weight. All experimental procedures were conducted in 
conformity with institutional guidelines for the care and 
use of laboratory animals in Tunisia, and the international 
guidelines on the ethical use of animals (NIH publications 
No. 80-23).
Plant material
Cinnamon (Cinnamomum zeylanicumon) dried 
barks were purchased on the Tunisian local market 
and they were botanically identified by Professor 
Abderrazek Smaoui (Biotechnology Center in Borj-Cedria 
Technopole, Tunisia). Then, Cinnamon dried barks were 
sorted and reduced to powder in a clean household blender. 
Conservation of the powder thus obtained was made in 
the absence of light and moisture. Cinnamon powder was 
mixed with the standard feed at a 5% rate.
Phytochemical screening
A qualitative phytochemical test to detect the 
presence of alkaloids, flavonoids, saponins, steroids, 
tannins, coumarins and phenols was carried out using 
standard procedures (Poongothai et al., 2011; Yadav, 
Agarwala, 2011; Saxena, Sahu, 2012; Benmahdi et al., 
2012).
Induction of diabetes in experimental animals
Diabetes was induced in rats by an intraperitoneal 
injection of alloxan in a single dose of 15 mg/kg. alloxan 
was dissolved in a freshly prepared 0.01 M sodium acetate 
buffer (0.154 M, pH 4.5) while control rats were injected 
with buffer alone (Raju et al., 2001). Alloxan-injected 
animals were given 5% glucose (2 mL/kg body weight) 
at 12 h to prevent initial drug-induced hypoglycemic 
mortality. Blood was drawn from the tail plexus of 
conscious rats using a heparinized inoculator 7 days later.
Experimental design
The rats were randomly divided into four groups. 
Group I: control animals (n=6) receiving the standard 
diet. Group II: alloxan-diabetic animals (n=6) receiving 
standard diet. Group III: control animals given standard 
diet with cinnamon (n=6). Group IV: alloxan-diabetic 
animals given standard diet with cinnamon (n=6). 
After 28 days, the animals were deprived of food 
overnight, sacrificed by decapitation, and then used in series 
of studies. Blood was collected from the jugular vein with 
heparin as anticoagulant and centrifuged at 1000 × g for 10 
minutes to separate plasma (concerved at -20 °C). Assays 
were carried in plasma for triglycerides, cholesterol, serum 
proteins and enzymes of oxidative stress.
The body was cut open, and then the pancreas was 
removed and washed in ice-cold saline (NaCl 0.9% at 
2 ± 2 °C). At a fraction of 0.4 g of pancreas, we added 
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4 mL of a solution of phosphate buffered saline (pH = 7.4), 
centrifuged at 3000 r/min for 30 min. The supernatant was 
collected and conserved at -80 °C for further investigations.
Glucose levels and lipid profile 
Concentration of blood glucose was tested using a 
Diagnostic kit with test strips (On Call Advanced: Acon 
Laboratories, Inc.). Blood glucose was measured on the 7th, 
14th, 21st and 28th days to assess the blood glucose-lowered 
effect of cinnamon. Rats with blood glucose at 2 g/L were 
considered diabetic. Protein level in plasma was determined 
by means of a colorimetric assay kit specific for total protein 
(Yacoubi et al., 2011). The levels of protein were expressed 
in g/L. The serum concentrations of total cholesterol and 
triglycerides were determined using colorimetric kits 
(Henry, Cannon, Winkelman, 1979).
Antioxidant defense system assays
The activities of three antioxidant enzymes: SOD, 
CAT and GPx were determined in pancreas homogenate 
and in serum. SOD activity was measured according to 
the method of Beyer and Fridovich (1987), CAT activity 
was determined using the method of Aebi (1984) and GPx 
activity was measured according to the method of Flohe 
and Gunzler (1984).
RESULTS
Phytochemical screening
The phytochemical screening of cinnamon revealed 
the presence of alkaloids, coumarins, flavonoids, saponins, 
carbohydrates, steroids, tannins and phenols. However, 
proteins and glycosides were not detected (Table I). 
Effect of cinnamon on body weight 
Table II showed the average values of the body 
weight of different rat groups. All rats started the study 
with a comparable weight and no statistically significant 
difference (P ≤ 0.05) was found between the four groups. 
The rats in the control groups (groups I and III) 
showed a normal increase in weight over time. Cinnamon 
supplementation has no effect on the weight.
Alloxan-diabetic animals receiving standard diet 
(group II) showed a significant (P ≤ 0.05) weight loss that 
continued until the end of the experiment at approximately 
8%, 15% and 21.63% compared with initial body weight. 
At the end of the experiment, the average weight of alloxan-
diabetic rats was statistically lower (P ≤ 0.05) than controls.
For the group IV of diabetic rats receiving cinnamon, 
there was a significant loss (P ≤ 0.05) of body weight. 
Compared with alloxan-diabetic rats that did not receive 
cinnamon, we found a significant increase (P ≤ 0.05) in 
their body weight of about 1.2% (day 7), 5.55% (day 14), 
TABLE I – Qualitative phytochemical screening of cinnamon 
powder 
Cinnamon powder
Alkaloids +
Carbohydrates +
Coumarins +
Flavonoids +
Glycosides -
Phenols +
Proteins -
Saponins +
Steroids +
Tannins +
Sign (+) indicates present and sign (−) indicates absent
TABLE II - Effect of cinnamon powder supplementation on body weight in normal and alloxan-diabetic rats
Groups‡
Weight (g )†
Day 0 Day 7 Day 14 Day 21 Day 28
Group I 214.2 ± 10.7b 227.5± 6.9b 239.3± 8.12ab 251± 8.6a 264.3± 10.2a
Group II 217.5± 6.1a 209.3± 6.8b 203.5± 6.5b 196.7± 5.09bc 186.7± 10.2c
Group III 205± 11d 217.2± 10.4c 227.5± 9.3bc 238.7± 8.6b 249.5± 8.3a
Group IV 210± 11.4b 211.8± 13.2b 214.8± 10.3b 216± 8.9b 221.5± 10.3a
†: mean values ± standard error, number of rats=6. ‡: Group I: control animals receiving the standard diet. Group II: alloxan-diabetic 
animals receiving standard diet. Group III: control animals given standard diet with cinnamon. Group IV: alloxan-diabetic animals 
given standard diet with cinnamon. Different letters within each line indicate significant differences at P ≤ 0.05 as determined by 
Duncan’s multiple range tests.
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9.81 % (day 21) and 18.64 % (day 28).
Effect of cinnamon on blood glucose
Table III represents the effect of cinnamon on the 
blood glucose profile of treated rats. Cinnamon did not 
alter blood sugar levels in control rats. Glucose profiles 
were nearly similar in rat groups I and III.
Furthermore, the treatment with alloxan caused 
a significant increase (P ≤ 0.05) in blood glucose for 
rat groups II and IV from the beginning of treatment 
compared to the untreated rats (groups I and III). This 
increase was maintained throughout the experiment. 
Hyperglycemia was increased from 344.4 ± 35 mg/dL on 
the beginning to 353.7 ± 30.4 mg/dL on the 7th day and 
remained elevated on the other days of the experiment to 
reach 342.2 ± 23.9 mg/dL on the 28th day.
The cinnamon administration in diabetic rats caused 
an important and significant drop (P ≤ 0.05) in blood 
glucose. The values significantly (P ≤ 0.05) decreased 
from 337.2 ± 29.8 to 171 ± 18.7 mg / dl after 28 days 
of treatment. This effect was early manifested when 
cinnamon was administrated to rats.
Influence of cinnamon on lipid profile
Two lipid parameters were followed in this study: 
cholesterol and triglycerides (Table IV). 
The induction of diabetes by alloxan led to an 
increase in plasma lipids levels. The triglycerides 
significantly (P ≤ 0.05) increased from 0.41 ± 0.03 g/L at 
the beginning to 0.94 ± 0.27 at the end of experiment. The 
same results were shown for cholesterol: from 0.66 ± 0.16 
to 0.90 ± 0.03  g/L (P ≤ 0.05). These disturbances of lipid 
metabolism caused by diabetes were partially corrected 
by cinnamon. 
Triglyceride levels were slightly decreased for the 
group III compared to group I when cinnamon was added. 
This difference was not statistically significant at P ≤ 0.05. 
A significant reduction (P ≤ 0.05) in cholesterol level was 
observed after administration of cinnamon for the group 
IV compared to the group II.
Antioxidant enzyme activities
The activities of SOD, CAT and GPx in pancreas are 
given in Table V. Results showed a significant reduction (P 
≤ 0.05) in the activity of SOD in the pancreas in untreated 
alloxan-diabetic compared to control rats from group I. 
The SOD activity significantly (P ≤ 0.05) increased in the 
pancreas from 11.3 ± 1.2 U/mg of protein to 20.2 ± 3.4 
U/mg of protein among alloxan-diabetic rats treated with 
cinnamon comparing to those not receiving cinnamon. 
Cinnamon administration to the group IV did not 
significantly change the activity of SOD in the pancreas 
at P ≤ 0.05.
TABLE III - Effect of cinnamon powder supplementation on body glucose in normal and alloxan-diabetic rats
Weight (g) †
Day 0 Day 7 Day 14 Day 21 Day 28
Group I 86.6± 3.6a 88.6± 2.5a 86± 2.4a 88.1± 3.6a 88.6± 4.8a
Group II 344.4± 35a 353.7± 30.4a 308.5± 14.5b 332.7± 20.7a 342.2± 23.9a
Group III 85.6± 3.6a 87.6± 3.5a 85.5± 4.5a 84.4± 3.3a 85.4± 7.3a
Group IV 337.2± 29.8a 249.7± 33.9b 208.5± 25.6c 186.6± 19cd 171± 18.7e
†: mean values ± standard error, number of rats=6. ‡: Group I: control animals receiving the standard diet. Group II: alloxan-diabetic 
animals receiving standard diet- Group III: control animals given standard diet with cinnamon. Group IV: alloxan-diabetic animals 
given standard diet with cinnamon. Different letters within each line indicate significant differences at P ≤ 0.05 as determined by 
Duncan’s multiple range tests.
TABLE IV - Effect of cinnamon powder supplementation on lipid profile in normal and alloxan-diabetic rats
Groups Group I Group II Group III Group IV
Triglycerides [g/L ] 0.41±0.03c 0.94±0.27a 0.36±0.12d 0.50±0.29b
Cholesterol [g/L ] 0.66± 0.16c 0.90±0.03a 0.58±0.12d 0.77±0.30b
Mean values ± standard error, number of rats=6. Different letters within each line indicate significant differences at P ≤ 0.05 as 
determined by Duncan’s multiple range tests.
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The induction of diabetes in rats by alloxan provoked 
a significant reduction (P ≤ 0.05) of the CAT activity of 
about 48.22% (from 50.6 ± 5 to 26.2 ± 2.9mol H2O2 / min 
/ mg of protein). An insignificant increase (P ≤ 0.05) of 
the pancreatic CAT activity was observed in the group of 
control rats treated with cinnamon (group III) compared 
to normal rats (group I). Treatment of alloxan-diabetic rats 
with cinnamon caused a significant increase (P ≤ 0.05) 
of 41.6% in the activity of pancreatic CAT compared to 
group II (from 26.2 ± 2.9 to 37.1± 4.9 mol H2O2/min/mg 
of protein). 
In alloxan-diabetic rats, a significant increase 
(P ≤ 0.05) of GPx was detected (0.6 ± 0.2 vs 2.3 ± 0.4 10-3 
mM/min/mg) compared with the control rats. Cinnamon 
caused a significant elevation (P ≤ 0.05) of GPx in alloxan-
diabetic animals receiving cinnamon in contrast to those 
receiving normal diet. Supplementation of cinnamon 
caused a significant elevation (P ≤ 0.05) of SOD, CAT and 
GPx in plasma of alloxan-diabetic rats (Table VI).
DISCUSSION
Diabetes mellitus, the most common endocrine 
disease, is not a single disease but a group of disorders. In 
fact, hyperglycemia, polyphagia, polydipsia and reduction 
in body weight are frequently observed in the state of 
diabetes. In the present study, induction of diabetes by 
alloxan also produced a decrease in body weight. The 
cinnamon administration showed a significant increase of 
weight compared to diabetic control rats. Decrease in body 
weight of diabetic rats was possible due to catabolism of 
fats and protein, even though the food intake was more in 
diabetic rats than control. Due to insulin deficiency, protein 
content was decreased in muscular tissue by proteolysis 
(Vats, Yadav, Grover, 2004). Similar results were obtained 
by Mahmood et al. (2011) and El Desoky et al. (2012) 
who reported a decrease of weight in alloxan diabetic rats. 
As shown in this study, cinnamon was an effective agent 
contributing to the reduction of glucose levels in serum. 
The high serum glucose level induced by alloxan was 
decreased by the cinnamon powder supplementation for 
50.02% during the fourth week of treatment (p < 0.001). 
Our results corroborated the findings of Mahmood et 
al. (2011) about the elevation of blood glucose level in 
alloxan-induced diabetic rats, and a reduction in this level 
after cinnamon extract administration. Rekha, Balaji and 
Deecaraman (2010) reported that the increased levels of 
plasma glucose in streptozotocin-induced diabetic rats were 
lowered by the administration of cinnamon extract. Mahera 
(2010) and Ping, Zhang and Ren (2010) reported that oral 
TABLE V - Effect of cinnamon powder supplementation on the activity of SOD, CAT and GPx in the pancreas in normal and 
alloxan-diabetic rats
SOD 
(U/mg of protein)
CAT 
(Mol H2O2/min/mg of protein )
GPx 
(10-3mM/min/mg )
Group I 20.2 ± 2.5b 50.6 ± 5a 2.3 ± 0.4a
Group II 11.3 ± 1.2c 26.2 ± 2.9c 0.6 ± 0.2c
Group III 23.6 ± 2.6a 51.5 ± 4a 2.5 ± 0.4a
Group IV 20.2 ± 3.4b 37.1 ± 4.9b 1.2 ± 0.2b
Group I: control animals receiving the standard diet. Group II: alloxan-diabetic animals receiving standard diet. Group III: control 
animals given standard diet with cinnamon. Group IV: alloxan-diabetic animals given standard diet with cinnamon. Different letters 
within each column indicate significant differences at P ≤ 0.05 as determined by Duncan’s multiple range tests.
TABLE VI - Effect of cinnamon powder supplementation on SOD, CAT and GPx activities in plasma of normal and alloxan-diabetic 
rats
Groups SOD (U/mL) CAT (U/mL) GPx (U/mL)
Group I 259.45 ± 6.325a 3.96 ± 0.28b 937.00 ± 37.12c
Group II 158.45 ± 5.07c 1.91 ± 0.26d 764.62 ± 30.27b
Group III 259.07 ± 7.10a 4.46 ± 0.44a 795.37 ± 318.34a
Group IV 249.05 ± 13.37b 3.82 ± 0.47c 779.69 ± 312. 50ab
Group I: control animals receiving the standard diet. Group II: alloxan-diabetic animals receiving standard diet. Group III: control 
animals given standard diet with cinnamon. Group IV: alloxan-diabetic animals given standard diet with cinnamon. Different letters 
within each column indicate significant differences at P ≤ 0.05 as determined by Duncan’s multiple range tests.
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administration of cinnamon essential oil significantly 
reduced the blood glucose level in diabetic rats which could 
be due to a reversal of insulin resistance or increasing insulin 
secretion by the regeneration of damaged pancreatic β-cells 
in alloxan-induced diabetic rats. Additionally, flavonoids are 
also known to regenerate the damaged β-cells in the alloxan-
induced rats and act as insulin secretagogues (Alagammal, 
Agnel, Mohan, 2012). In this way, Anitha et al. (2012) 
reported that flavonoids, steroids, terpenoids and phenolic 
acids are known to be bioactive anti-diabetic components. 
According to Tacouri, Ramful-Babbolall and Puchooa 
(2013) and Pandey, Pandey and Singh (2014), these potent 
phytochemicals have been detected in cinnamon extract. 
In diabetes, the levels of plasma lipids are usually 
raised and such an elevation represents a risk factor for 
coronary heart disease (Grundy, 1999). Also, an increase 
in levels of plasma cholesterol, phospholipids, free 
fatty acids and triglycerides was observed in alloxan 
diabetic rats. The abnormally high concentration of 
plasma lipids in diabetes is mainly due to the increase in 
the mobilization of free fatty acids from the peripheral 
depots, since insulin inhibits the hormone sensitive lipase 
(Dhandapani et al., 2002). In the present study, there was 
a decrease in levels of triglyceride and cholesterol in 
diabetic alloxan rats treated with cinnamon. Blevins et 
al. (2007) reported that oral administration of cinnamon 
(20 mg/Kg body weight) significantly decreased serum 
total cholesterol, triglyceride levels and at the same time 
markedly increased plasma insulin. Amin and Abd El-
Twab (2009) proposed that cinnamon extract may improve 
the postprandial overproduction of intestinal apoB48-
containing lipoproteins by ameliorating intestinal insulin 
resistance and may be beneficial in the control of lipid 
metabolism. However, treatment with cinnamon essential 
oil significantly decreased and improved the diabetic status 
including protection of DNA against oxidative damage 
and hypocholesterolemic effect (Thresa, Christieand, 
Andrea, 2004). These results were in agreement with 
the study proposed by Anderson et al. (2004) which 
revealed that the polyphenols, polymers and anthocynins, 
found in cinnamon functions as antioxidants, potentiate 
insulin action and may be beneficial in the control of 
glucose intolerance and diabetes. Cao, Polansky and 
Anderson (2007) also reported that cinnamon extract and 
polyphenols improved the lipid profile of people with 
type 2 diabetes. On the other hand, our results showed a 
significant decrease in TG and TC levels in cinnamon-
treated rats. Similar results were obtained by Qin et al. 
(2003) who reported that TG and TC were decreased by 
administration of cinnamon extract in rats treated with 
streptozotocin for 3 weeks. 
Diabetes mellitus is strongly associated with 
oxidative stress, which can be a consequence of either 
increased production of free radicals, reduced antioxidant 
defense or both (Vijayalingam et al., 1996). One of the 
most important therapeutic strategies for this disease 
is modulating insulin resistance and oxidative stress. 
The evaluation of oxidative stress can be monitored by 
several biomarkers. In this study, we choose to measure 
the activities of SOD, CAT and GPx which are known 
as protective enzymes against free radical formation 
in tissues. The induction of diabetes in rats by alloxan 
provoked a significant reduction of SOD, CAT and GPx 
levels in the pancreas. The treatment with cinnamon 
for four weeks significantly increased to near normal 
levels of SOD, CAT and GPx in the pancreas. These 
results revealed the protective role of cinnamon powder 
in decreasing lipid peroxidation and by normalizing 
antioxidant systems. Suganthi et al. (2007) evaluated 
a spice mixture of cinnamon for its effect on oxidative 
stress markers and antioxidant potential in tissues of high 
fructose-fed insulin-resistant rats. Administration of the 
spice mixture along with dietary fructose reduced the 
levels of peroxidation markers in tissues and improved 
the antioxidant status compared to rats receiving dietary 
fructose alone. Halvorsen et al. (2006) generated a ranked 
food table with values for total content of redox-active 
compounds and ground cinnamon ranked fourth with 
regard to total antioxidant content (17.647 mM/100 g). 
CONCLUSION
Controlling the levels of glucose, cholesterol, 
triglycerides and activities antioxidant enzymes in rats 
treated with the cinnamon may be an encouraging result 
for an alternate treatment for diabetes.
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